AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI)
CUSIP: 00901B105
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 67,129,058
- Total 13F shares
- 6,001,972
- Share change
- -711,141
- Total reported value
- $4,680,348
- Price per share
- $0.78
- Number of holders
- 29
- Value change
- -$590,475
- Number of buys
- 10
- Number of sells
- 11
Quarterly Holders Quick Answers
What is CUSIP 00901B105?
CUSIP 00901B105 identifies AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00901B105:
Top shareholders of AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
|
Company |
3%
|
1,992,129
|
$2,112,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
3%
|
1,987,595
|
$2,107,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.2%
|
828,543
|
$878,000 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.64%
|
428,071
|
$454,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.56%
|
372,953
|
$395,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.26%
|
173,103
|
$183,000 | — | 31 Mar 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.24%
|
161,000
|
$171,000 | — | 31 Mar 2022 | |
| Verition Fund Management LLC |
13F
|
Company |
0.23%
|
153,000
|
$162,000 | — | 31 Mar 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.17%
|
116,800
|
$124,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.13%
|
88,707
|
$94,000 | — | 31 Mar 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.12%
|
83,557
|
$89,000 | — | 31 Mar 2022 | |
| Virtu Financial LLC |
13F
|
Company |
0.08%
|
50,805
|
$54,000 | — | 31 Mar 2022 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.07%
|
46,678
|
$49,000 | — | 31 Mar 2022 | |
| SeaCrest Wealth Management, LLC |
13F
|
Company |
0.06%
|
40,063
|
$42,000 | — | 31 Mar 2022 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.06%
|
40,000
|
$42,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
27,563
|
$29,000 | — | 31 Mar 2022 | |
| CAPTRUST FINANCIAL ADVISORS |
13F
|
Company |
0.03%
|
20,000
|
$21,000 | — | 31 Mar 2022 | |
| LPL Financial LLC |
13F
|
Company |
0.02%
|
16,482
|
$17,000 | — | 31 Mar 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
15,000
|
$16,000 | — | 31 Mar 2022 | |
| Community Bank, N.A. |
13F
|
Company |
0.02%
|
13,226
|
$14,000 | — | 31 Mar 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.02%
|
13,033
|
$14,000 | — | 31 Mar 2022 | |
| Traynor Capital Management, Inc. |
13F
|
Company |
0.02%
|
11,777
|
$12,000 | — | 31 Mar 2022 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.02%
|
10,800
|
$11,000 | — | 31 Mar 2022 | |
| SNS Financial Group, LLC |
13F
|
Company |
0.01%
|
10,000
|
$11,000 | — | 31 Mar 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
10,000
|
$11,000 | — | 31 Mar 2022 | |
| HOWE & RUSLING INC |
13F
|
Company |
0%
|
1,500
|
$2,000 | — | 31 Mar 2022 | |
| Stephens Consulting, LLC |
13F
|
Company |
0%
|
1,500
|
$1,590 | — | 31 Mar 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
1,048
|
$1,000 | — | 31 Mar 2022 | |
| HOEY INVESTMENTS, INC |
13F
|
Company |
0%
|
1,000
|
$1,000 | — | 31 Mar 2022 | |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. |
13F
|
Company |
0%
|
500
|
$1,000 | — | 31 Mar 2022 | |
| Cordasco Financial Network |
13F
|
Company |
0%
|
500
|
$1,000 | — | 31 Mar 2022 | |
| American Portfolios Advisors |
13F
|
Company |
0%
|
228
|
$242 | — | 31 Mar 2022 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0%
|
170
|
$226 | — | 31 Mar 2022 | |
| Ellen M. Lintal |
3/4/5
|
Former Chief Financial Officer |
—
class O/S missing
|
50,000
|
— | — | 04 Apr 2022 |
Institutional Holders of AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI) as of Q2 2022
As of 30 Jun 2022,
AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,001,972 shares.
The largest 10 holders included
VANGUARD GROUP INC, MORGAN STANLEY, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Verition Fund Management LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, PRICE T ROWE ASSOCIATES INC /MD/, and NORTHERN TRUST CORP.
This page lists
29
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
30
Q2 2022 holders
29
Holder diff
-1
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.